Tag: Sumitomo Pharma

  • Why Myovant Sciences is Up Nearly 40%

    Why Myovant Sciences is Up Nearly 40%

    Keep an eye on Myovant Sciences (MYOV). The stock is up more than $6.88 on the day on a volume spike to 6.4 million, as compared to daily average volume of 750,453. All after the company rejected a buyout offer from Sumitomo Pharma and its wholly owned subsidiary Sumotivant Biopharma.  At the moment, Sumitovant owns…